Population Health Management and Data Analytics
Most companies waste between 35%-65% of their medical spending each year. Unfortunately, it can be almost impossible for an organization to identify and implement the right strategies that decrease spending, while still providing a rich benefits plan. Alera Group’s dedicated team of population health management and data analytics experts have the right tools and in-house expertise to conduct a deep analysis of your data organization's data. Our team can help you implement the right strategies and benefits plan to contain health spending, while meeting the diverse needs of your population. Our experts will:
- Integrate data by plan member into a comprehensive view of the entire organization’s population
- Leverage the right data to make long-term strategic plan decisions that help control healthcare costs
- Implement data modeling to identify opportunities to incentivize employee behavior to impact health spending
- Evaluate employee data, such as risk categories that impact health costs and strategies
- Analyze high-risk populations to implement strategic solutions that lead to targeted savings
- Utilize comparison modeling to compare providers and select the best provider and plan for your organization.
Our team will work with you to identify cost drivers and implement strategies that empower healthier employees and a more profitable organization.
Population Health Information
Insights You Need to Control Benefits Spending.
EXPERT EDUCATION
Events and Webinars
Employee Benefits
Driving Communications and Engagement: Open Enrollment
Our experts will walk you through a strategic planning process to make sure you’re sharing in a way that not only drives employee awareness and engagement but also reaches your workforce across platforms with what they need to know about choosing the right benefits for them and their families.
August 15, 2024 at 01:00 pm CT | Virtual
Sign Up
Employee Benefits
Q3 Compliance Update
Alera Group's quarterly employee benefits compliance roundup will help you stay current on the latest national regulatory developments impacting employers.
September 3, 2024 at 01:00 pm CT | Virtual
Sign Up
Employee Benefits
Is Tech-Enabled Brokerage Right for You?
Our experts will lay out what tech-enabled brokerage is, how it works and why it makes sense for the right organizations.
September 19, 2024 at 01:00 pm CT | Virtual
Sign Up
THOUGHT LEADERSHIP
Insights
Employee Benefits
Benefits Benchmarking Webinar: What To Do With the Data
If you’re designing your company’s employee benefits program, you want to know what your peers and competitors are offering. Employee retention and talent acquisition are largely dependent on whether you offer a benefits package that meets or exceeds the standards of your industry, location and company size while managing costs in an increasingly expensive market for healthcare and pharmaceuticals. That’s why Alera Group places a high priority on using benchmarking data and analysis to inform and otherwise serve our clients.
July 1, 2024
Find out more
Employee Benefits
How To Lower Healthcare Costs While Improving Benefit Offerings
Join us on June 20 for a one-hour webinar designed to help you eliminate wasteful healthcare spending while providing your employees with benefits that attract and retain talent. We’ll take you through our three-step solution.
June 11, 2024
Find out more Employee Benefits
Legal Alert: PCORI Fees Due by July 31, 2024
Employers that sponsor self-insured group health plans, including health reimbursement arrangements (HRAs) should keep in mind the upcoming July 31, 2024, deadline for paying fees that fund the Patient-Centered Outcomes Research Institute (PCORI) via Form 720, which was recently updated and released by the IRS.
June 7, 2024
Find out more Employee Benefits
Webinar: Weight-Loss Drugs and Group Health Plans | Alera Group
Rising pharmacy costs are among the chief drivers of healthcare expenses for employers and employees, thanks largely to a surge in use of drugs you’ve seen advertised in those ubiquitous commercials. Given the cost of such drugs and their mixed record of success, employers and employees should exercise caution.
February 6, 2024
Find out more